SynBioBeta Speaker
Una Ryan
Ulux
Founder and CEO
As CEO of several public , private and nonprofit companies, I have overseen many trials from phase 1 through approval. I am familiar with global national and orphan indications.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Una
This Year
•
-
Human Health
Rewriting the Rules - Clinical Trial Reform in the Age of AI
AI-native drug discovery is accelerating molecule design, but clinical trials remain slow, expensive, and exclusionary. If we don’t modernize trial infrastructure, we create a bottleneck between computational breakthroughs and real-world patient impact. This breakout explores how to reform recruitment, eligibility, endpoints, biomarkers, and regulatory alignment to make U.S. trials more competitive and globally scalable.
Get a Ticket
Featuring
Zachary Gobst
Leapcure
CEO
Making clinical trials more equitable and accessible.
Jacob Becraft
Strand
CEO & Co-founder
MIT “mRNA programming language” inventor building programmable RNA medicines. Former Ron Weiss lab, interned with Bob langer
Jacob Glanville
Centivax
CEO
Building a universal antivenom
Una Ryan
Ulux
Founder and CEO
•
-
Human Health
Rewriting the Rules - Clinical Trial Reform in the Age of AI
AI-native drug discovery is accelerating molecule design, but clinical trials remain slow, expensive, and exclusionary. If we don’t modernize trial infrastructure, we create a bottleneck between computational breakthroughs and real-world patient impact. This breakout explores how to reform recruitment, eligibility, endpoints, biomarkers, and regulatory alignment to make U.S. trials more competitive and globally scalable.
Get a Ticket
Featuring
Zachary Gobst
Leapcure
CEO
Making clinical trials more equitable and accessible.
Jacob Becraft
Strand
CEO & Co-founder
MIT “mRNA programming language” inventor building programmable RNA medicines. Former Ron Weiss lab, interned with Bob langer
Jacob Glanville
Centivax
CEO
Building a universal antivenom
Una Ryan
Ulux
Founder and CEO
Session lineup still growing
Get a Ticket
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Get a Ticket
Featuring
Speaker Coming Soon
